This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated GABRG2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GABRG2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~55.2 kDa | |
| Observed band | Approximately 50 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | N-glycosylation alters mobility | |
| Regulation | LPS-induced | |
| Isoform | 3 isoform(s) |
Literature-validated Western blot parameters for GABRG2 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | rat brain , Lane 2: rat brain . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-GABA A Receptor gamma 2/GABRG2 antigen affinity purified polyclonal antibody (Catalog # A02361-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for GABA A Receptor gamma 2/GABRG2 at approximately 50KD. The expected band size for GABA A Receptor gamma 2/GABRG2 is at 50KD |
| Gel % | 10–12% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 50 kDa |
GABRG2 has a 55.2 kDa precursor backbone but runs at approximately 50 kDa in brain lysate because signal-peptide cleavage outweighs the mass added by its three N-glycans.
| Single band at approximately 50 kDa | This is the mature, signal-peptide-cleaved and glycosylated form of GABRG2, matching the empirical band reported for brain tissue lysate |
| Band running below the 55.2 kDa predicted precursor mass | Cleavage of the 39-residue N-terminal signal peptide removes mass from the full-length translation product, pulling the mature band under the predicted size |
| Slightly diffuse or broadened band rather than a razor-sharp line | Heterogeneous occupancy and processing of the three N-linked glycosylation sites (Asn52, Asn129, Asn247) adds variable carbohydrate mass across molecules |
| More than one band at distinct apparent masses | Co-expression of different GABRG2 splice isoforms (1, 2, 3) with differing exon content in the sample |
| Weak or absent signal in a crude whole-cell lysate without membrane enrichment | GABRG2 is a multi-pass postsynaptic/plasma membrane protein, so unenriched preparations under-represent it relative to membrane-fraction lysates |
| No change in band position between reducing and non-reducing conditions | The single Cys190-Cys204 disulfide is intrachain, stabilizing the extracellular fold rather than linking separate monomers, so it does not create a higher-mass dimer band |
| Predicted mass from UniProt (55.2 kDa) | Sets the baseline unmodified backbone size before any cleavage or modification is applied |
| Signal peptide cleavage (residues 1-39) | Removes the N-terminal signal sequence from the mature protein, lowering the apparent mass to around the observed 50 kDa rather than the 55.2 kDa precursor |
| N-glycosylation at Asn52, Asn129, and Asn247 | Adds carbohydrate mass and can broaden the band, partially offsetting the mass lost to signal-peptide cleavage |
| Three named splice isoforms (1, 2, 3) | Differential exon usage among isoforms can yield additional bands at slightly different apparent masses depending on which isoform(s) a sample expresses |
| Single intrachain disulfide bond (Cys190-Cys204) | Stabilizes the extracellular cys-loop fold but does not crosslink separate chains, so it does not shift the monomer band size under reducing or non-reducing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | GABRG2 is a multi-pass membrane protein concentrated in postsynaptic membranes and is not efficiently solubilized by mild lysis conditions | Use a detergent-based lysis buffer (e.g. RIPA or 1% Triton/NP-40) and enrich for the membrane fraction before loading |
| Band higher than expected | Incomplete denaturation of the multi-pass transmembrane protein leaves residual complex or aggregate that migrates above 50 kDa | Increase SDS and heat denaturation time and confirm a reducing agent such as DTT or beta-mercaptoethanol is fresh and present |
| Band lower than expected | Loss of N-glycan mass, from deglycosylation treatment or a non-mammalian expression system lacking the modification, shifts the band below the normal 50 kDa | Compare against an untreated mammalian-expressed positive control or a PNGase F-treated reference lane |
| Broad smear instead of sharp band | Heterogeneous occupancy and processing at the three N-linked glycosylation sites produces microheterogeneity in apparent mass | Extend gel run time for better resolution or treat an aliquot with PNGase F to collapse the smear into a single deglycosylated band |
| Multiple bands | Detection of more than one of the three GABRG2 splice isoforms, or partial proteolytic degradation of the membrane protein during lysis | Include protease inhibitors during lysis and compare the pattern to isoform-specific controls |
| Weak or no signal | GABRG2 is a minor subunit within the pentameric GABA-A receptor complex, so its relative abundance in total lysate is low | Enrich the synaptic membrane fraction or increase total protein loaded per lane |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for GABRG2, answered from its protein features.
BosterBio's GABRG2 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Boster's anti-GABRG2 antibody (A02361-1) is validated by Western blot, showing a specific band for GABRG2 at the expected size on SDS-PAGE—giving researchers a documented, image-backed starting point for reliable GABRG2 detection.
Which to pick: Only one Boster GABRG2 antibody is catalogued here, A02361-1, which includes an actual Western blot validation image—so it's the clear (and only) choice; confirm species/tissue reactivity against your sample before ordering.